Coming July 15, 2021
For US and Canadian customers:
Pre-order now and save 20%! Use code CHPD24us when ordering (the code is valid until July 18, 2021).
Quick and comprehensive information on psychotropic drugs for adults.
- Accurate and up-to-date
- Comparison charts help decision-making
- Icons and full color
- Available in print and online
- Downloadable patient info sheets
The Clinical Handbook of Psychotropic Drugs has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals.
- Independent, unbiased, up-to-date
- Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions…) for a quick overview of treatment options
- Succinct, bulleted information on all classes of medication: on- and off-label indications, (US FDA, Health Canada), recommended dosages, US and Canadian trade names, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more – all you need to know for each class of drug
- Potential interactions and side effects summarized in comparison charts
- With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek
- Clearly written patient information sheets available for download as printable PDF files
This book is a must for everyone who needs an up-to-date, easy-to-use, comprehensive summary of all the most relevant information about psychotropic drugs.
New in this edition
- Neuroscience-based nomenclature – added to product availability tables
- Antidepressants chapter includes new section on GABAA receptor positive modulator (brexanolone IV injection; trade name Zulresso); also covers Qelbree (viloxazine extended-release capsules), the first new ADHD medication approved by the FDA in over a decade; as well as updates to SSRI use in pregnancy and antidepressant augmentation strategies
- Antipsychotics updates include revised dosing, especially adjustments in hepatic and renal impairment
- Mood stabilisers chapter sections on lithium and anticonvulsants extensively revised
- New formulations and trade names include: Adhansia XR (methylphenidate extended-release capsules), Caplyta(lumateperone), Dayvigo (lemborexant), Perseris (risperidone extended-release subcutaneous injection), Probuphine (buprenorphine subdermal implant), Propecia (finasteride tablets), Trelstar (triptorelin slow-release injection), Qelbree (viloxazine extended-release capsules)
Previous praise for the Clinical Handbook
“This is the new edition [23rd] of a very important book that provides valuable information which otherwise would be scattered among different publications. With the increasing rate of prescription of psychotropic drugs, this volume should be on the desk of every physician. The information is crucial for understanding side effects, vulnerabilities, and interactions of psychotropic drug treatment.”
Giovanni A. Fava, MD, in Psychotherapy and Psychosomatics, 2019
“As a psychiatrist who routinely prescribes medications, I find this handbook invaluable. It is the most comprehensive book on this topic that I have come across.”
Corey Goldstein, MD, Rush University Medical Center
“A powerhouse of practical information ...Unrivalled in scope ... This outstanding and unique handbook is as rich in useful content as many full textbooks.”
Barbara Jovaisas, PharmD, in Canadian Pharmacists Journal
“Comprehensive … clearly organized … an ideal resource for rapid and straight-forward retrieval of essential clinical information ... a ‘must have’ for those who work in mental health care.”
Marshall Cates, PharmD, in Annals of Pharmacotherapy
“Should be available at all nursing stations.”
C. Lindsay DeVane, PharmD, in American Journal of Health Systems Pharmacy
“The handbook is easy to use, comprehensive in scope, and up to date – a winner!"
Catherine Chiles, MD, in the Journal of Clinical Psychiatry
